These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 2522729)
21. Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol. Luurila OJ; Gröhn P; Heikkilä J; Hämäläinen L; Härkönen R; Idänpään-Heikkilä U; Kohvakka A; Rytkönen U; Setälä M; Sundberg S Am J Cardiol; 1987 Oct; 60(10):832-5. PubMed ID: 3310576 [TBL] [Abstract][Full Text] [Related]
22. A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension. Giorgi G; Legramante JM; Fioravanti G; Paies G; Legramante A Am Heart J; 1988 Dec; 116(6 Pt 2):1801-5. PubMed ID: 2904754 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial. Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246 [TBL] [Abstract][Full Text] [Related]
24. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade. Leenen FH; Davies RA; Fourney A Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044 [TBL] [Abstract][Full Text] [Related]
25. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension. Torvik D; Madsbu HP Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870 [TBL] [Abstract][Full Text] [Related]
26. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension. Torvik D; Madsbu HP Am J Cardiol; 1987 May; 59(14):68G-72G. PubMed ID: 2884855 [TBL] [Abstract][Full Text] [Related]
27. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins. Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications. Zusman RM; Christensen DM; Higgins J; Boucher CA J Cardiovasc Pharmacol; 1992 Aug; 20(2):216-22. PubMed ID: 1381012 [TBL] [Abstract][Full Text] [Related]
29. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension. Young RA; Brogden RN Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495 [TBL] [Abstract][Full Text] [Related]
30. Working ability and exercise tolerance during treatment of mild hypertension. II. A comparison between atenolol and prazosin medication. Lange Andersen K; Ottmann W; Piatkowski W; Green KA Int Arch Occup Environ Health; 1985; 56(1):49-55. PubMed ID: 3897071 [TBL] [Abstract][Full Text] [Related]
31. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension. Panfilov V; Morris AD; Donnelly R; Reid JL J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805 [TBL] [Abstract][Full Text] [Related]
33. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension. Myburgh DP; Gordon NF Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458 [TBL] [Abstract][Full Text] [Related]
34. Effect of atenolol or prazosin on maximal exercise performance in hypertensive joggers. Thompson PD; Cullinane EM; Nugent AM; Sady MA; Sady SP Am J Med; 1989 Jan; 86(1B):104-9. PubMed ID: 2913765 [TBL] [Abstract][Full Text] [Related]
35. A double-blind comparative study of doxazosin and prazosin in the treatment of essential hypertension. Fukiyama K; Omae T; Iimura O; Yoshinaga K; Yagi S; Inagaki Y; Ishii M; Kaneko Y; Yamada K; Ijichi H Am Heart J; 1991 Jan; 121(1 Pt 2):317-22. PubMed ID: 1824654 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of doxazosin in hypertension therapy. Hayduk K Am J Cardiol; 1987 May; 59(14):35G-39G. PubMed ID: 2884851 [TBL] [Abstract][Full Text] [Related]
38. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension. Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861 [TBL] [Abstract][Full Text] [Related]
39. A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension. Nechwatal W; Berger J; Blumrich W; Bouzo H; Brandl K; Braun S; Laukaitis A; Müller G; Ryba W; Schreiegg J Am Heart J; 1988 Dec; 116(6 Pt 2):1806-14. PubMed ID: 2904755 [TBL] [Abstract][Full Text] [Related]
40. Exercise stress test in young hypertensive patients. Response to vasodilators (prazosin) vs. beta-blocker (atenolol) agents. Gimeno Gascón JV; Olague de Ros J; Ferrer Reig J; Hernandez Martinez M; Bordes Siscar P; Serra Flores J; Estruch Catala G; Algarra Vidal FJ Clin Cardiol; 1988 Jan; 11(1):24-34. PubMed ID: 3280191 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]